Open AccessNSCLC: MetMAb + Erlotinib Extends Survival in Subset of Lung Cancer Patients
Author(s) -
Charlene Laino
Publication year - 2010
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000392901.36077.50
Subject(s) - erlotinib , lung cancer , medicine , oncology , epidermal growth factor receptor , cancer , erlotinib hydrochloride , clinical trial , progression free survival , chemotherapy